Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.280NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.597NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.443NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.595.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.495NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.294NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.453NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.350NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.304NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.315NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FW.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.422NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.219NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.208NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.125.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.78 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.159NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.21.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EE.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ES.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.1.6.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.141NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.591NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used